1 October 2020
Latham Advises Invetx in US$25.5 Million Series A Financing
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Kristen Grannis Lead | Latham & Watkins LLP | Partner | corporate | Boston/New York |
| Spencer Ricks | Latham & Watkins LLP | Associate | corporate | Boston |
| Peter Prial | Latham & Watkins LLP | Associate | corporate | Boston |
| Tyler Mills | Latham & Watkins LLP | Associate | corporate | Boston |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 25.5m (US$25.5 million)
- What the figure measures
- Fund size
- Client
- InvetxIssuer
- Counterparties
- Casdin Capital (Investor)
Tekla Capital Management (Investor)
Anterra Capital (Investor)
AbCellera Biologics (Investor)
WuXi Biologics (Investor)